SCHEMBL7330708

SCHEMBL7330708

Nc1nnc(CCCCN2CCN(c3ccccn3)CC2)s1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 11/20 0.64
DRD3 P35462 11/20 0.64
DRD4 P21917 9/20 0.64
HTR1A P08908 6/20 0.64
HTR2A P28223 5/20 0.64
HTR7 P34969 5/20 0.64
DRD1 P21728 3/20 0.59
HTR2C P28335 3/20 0.59
ADRA2C P18825 2/20 0.59
HRH1 P35367 2/20 0.59
ADRA2A P08913 1/20 0.59
ADRA2B P18089 1/20 0.59
SLC6A2 P23975 1/20 0.59
ADRA1D P25100 1/20 0.59
HTR1D P28221 1/20 0.59
HTR1B P28222 1/20 0.59
HTR1E P28566 1/20 0.59
ADRA1A P35348 1/20 0.59
ADRA1B P35368 1/20 0.59
OPRM1 P35372 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7329469 0.96 DRD2 (0.64) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL9137868 0.85 DRD2 (0.59) DRD2DRD3DRD4HTR1AHTR2A
Hydrochloric Acid SCHEMBL7327180 0.82 SIGMAR1 (0.57) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL7329553 0.82 DRD2 (0.58) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL26108725 0.79 KCNH2 (0.85) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL26107525 0.79 KCNH2 (0.85) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL4519313 0.79 KCNH2 (0.85) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL10332824 0.78 DRD2 (0.63) DRD2DRD3DRD4HTR1AHTR2A
Hydrochloric Acid SCHEMBL7321381 0.78 SIGMAR1 (0.56) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL27237006 0.78 HTR1A (1.00) DRD2DRD3DRD4HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0592453-B1 AMINOALKYL-SUBSTITUTED 2-AMINO-1,3,4-THIADIAZOLES, THEIR PREPARATION AND THEIR USE BASF AG (DE) 1998-12-16 EP disclosed
US-5424312-A Treating central nervous system disorders, high blood pressure BASF AKTIENGESELLSCHAFT (DE) 1995-06-13 US disclosed
EP-0592453-A1 AMINOALKYL-SUBSTITUTED 2-AMINO-1,3,4-THIADIAZOLES, THEIR PREPARATION AND THEIR USE BASF Aktiengesellschaft (DE) 1994-04-20 EP disclosed
WO-1992022541-A1 AMINOALKYL-SUBSTITUTED 2-AMINO-1,3,4-THIADIAZOLES, THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1992-12-23 WO disclosed